BioVeris to Donate $1 Million of Products to Disaster Relief Efforts in Gulf Coast
16 September 2005 - 7:00AM
PR Newswire (US)
GAITHERSBURG, Md., Sept. 15 /PRNewswire-FirstCall/ -- BioVeris
Corporation (NASDAQ:BIOV) announced today that it will provide
assistance to aid the recovery efforts in the Gulf Coast following
Hurricane Katrina, including the donation of $1 million of
instrumentation and assays to be used for environmental, water and
food testing. The Honorable Asa Hutchinson, former Under Secretary
for Border and Transportation Security in the Department of
Homeland Security, and the Honorable Tommy Thompson, former
Secretary of the U.S. Department of Health and Human Services, have
agreed to assist BioVeris in the coordination of product placement.
As a result of the flooding that has occurred in the Gulf Coast,
many health facilities and laboratories across the region suffered
significant damage. In response to this situation, BioVeris will
contribute several of its proprietary diagnostic instruments and
test kits to aid in the detection of biological agents and toxins
in environmental, water and food samples. These agents include E.
coli 0157, cryptosporidium, botulinum toxins and others. BioVeris
also plans to provide trained experts to lend support in the use of
the products by the organizations engaged in the recovery efforts.
"We are extremely saddened by the devastation afflicting the Gulf
Coast region and our thoughts are with all the victims and their
families," said Samuel J. Wohlstadter, Chairman and Chief Executive
Officer of BioVeris. "The massive flooding and damage makes the
afflicted areas vulnerable to significant water and food
contamination. It is critical that these damaged regions are
equipped with the ability to quickly and accurately test water,
food and soil in the field. We hope that our instruments and
trained staff will help the recovery efforts during this time of
great need." BioVeris Corporation -- America's Biosecurity Company
-- is an integrated healthcare company developing proprietary
technologies in diagnostics and vaccinology. The Company is
dedicated to the commercialization of innovative products and
services for biosecurity and for healthcare providers, their
patients and their communities. BioVeris is headquartered in
Gaithersburg, Maryland. More information about the Company can be
found at http://www.bioveris.com/. DATASOURCE: BioVeris Corporation
CONTACT: George Migausky of BioVeris Corporation, +1-301-869-9800,
ext. 2013; Investors: Jonathan Fassberg of The Trout Group,
+1-212-477-9007, ext. 16; or Media: Paul Caminiti or Andrew Cole of
Citigate Sard Verbinnen, +1-212-687-8080 Web site:
http:/www.bioveris.com
Copyright
BIOVENTUS INC. (NASDAQ:BIOV)
Historical Stock Chart
From Aug 2024 to Sep 2024
BIOVENTUS INC. (NASDAQ:BIOV)
Historical Stock Chart
From Sep 2023 to Sep 2024
Real-Time news about Bioventus Inc. Class A Common Stock (MM) (NASDAQ): 0 recent articles
More Bioveris (MM) News Articles